...BRCA2 genes, the available literature with respect to outcomes related to radiation therapy has inherent limitations wit...
...BRCA2 mutation carriers in the allele contrast (OR = 1.11, 95% CI = 1.03-1.20), the homozygote codominant (OR = 1.23, 95...
...BRCA2 cause increased risk of developing various cancers, especially breast and ovarian cancers. Tumors that develop in ...
...BRCA2) risk factors are already known. Clinic manifestation is painless hard and fixed nodule in the subareolar region i...
Whether and to what extent germline mutations in the BRCA1 and BRCA2 genes increase the risk for developing uterine sero...
...BRCA2 mutation carriers with advanced cancers provide strong evidence for the clinical application of this approach. Eme...
...BRCA2, respectively). Four of the mutations, c.80+4del4, c.1938_1947del10 and c.1166delG in BRCA1 and c.6589delA in BRCA...
...BRCA2, PALB2, CDKN2a, RNASEL, STK11, NOD2, CHEK2 and PALLD, revealed deleterious causative germline mutations of BRCA2 a...
...Brca2 to pancreatic cancer we developed a mouse model of pancreas-specific Brca2 inactivation. Because BRCA2-inactivatin...
...BRCA2 (BCRA+) mutations has unearthed an early malignancy, serous tubal intraepithelial carcinomas (STIC), which has lin...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
